Streetbeat News

Stock Prices

WSM

Goldman Sachs has reaffirmed its Sell rating on Williams-Sonoma (NYSE:WSM) but increased its price target from $127.00 to $144.00. Despite the upgrade in the price target, the new target still suggests a potential downside of 16.6% from the current share price of $172.66. Williams-Sonoma is a leader in the home category with various brand extensions and is expanding in B2B and franchise areas.

Portfolio Pulse from Benzinga Insights

November 17, 2023 | 5:00 pm

TMO

Thermo Fisher Scientific (NYSE:TMO) has significantly outperformed the market with an average annual return of 19.53% over the past 15 years. An initial investment of $1000 in TMO 15 years ago would be worth $15,674.74 today. The company's current market capitalization stands at $180.05 billion.

Portfolio Pulse from Benzinga Insights

November 17, 2023 | 5:00 pm

CSIQ

UBS has maintained its Buy rating for Canadian Solar (NASDAQ:CSIQ) but reduced its price target from $47.00 to $36.00. Despite the lowered target, the new price suggests a significant upside of 72.74% from the current trading price of $20.84. Canadian Solar operates in the solar power industry, providing products and services across two segments: CSI Solar and Global Energy.

Portfolio Pulse from Benzinga Insights

November 17, 2023 | 5:00 pm

USO

Oil prices are facing their fourth consecutive weekly loss, with the market shifting to contango, indicating higher future prices. The December oil futures contract is trading at a discount to April 2024, reflecting current oversupply. The bear market has seen a 21% drop in prices since September 2023. The United States Oil Fund (USO) remains flat YTD. OPEC's upcoming meeting on Nov. 26 will address falling prices and global growth concerns. Goldman Sachs predicts a tighter oil market in 2024, with Brent prices likely maintained between $80-$100 by OPEC.

Portfolio Pulse from Piero Cingari

November 17, 2023 | 4:59 pm

CRSP

CRISPR Therapeutics' stock is trading higher following the announcement of regulatory authorization for the first CRISPR/Cas9 gene-edited therapy.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 4:57 pm

DXLG

Destination XL Group, Inc. (NASDAQ:DXLG) shares dropped after reporting Q3 net sales of $119.19 million, missing analyst expectations of $120.75 million and showing an 8.1% decline. Comparable sales decreased by 6.7% Y/Y due to reduced store traffic and transaction values amid economic and inflationary pressures. The company's adjusted EPS of $0.07 met expectations, but gross margin and adjusted EBITDA fell compared to the previous year. Destination XL also lowered its full-year sales and adjusted EPS outlook, leading to a 7.90% decline in its share price to $4.32.

Portfolio Pulse from Nabaparna Bhattacharya

November 17, 2023 | 4:56 pm

RR

Richtech Robotics, which may be referred to as RR in the article, has resumed trading of its shares. The article does not provide additional context such as the reason for the trading halt, the impact on the company's operations, or market reactions.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 4:49 pm

AEO

ANF

GPS

JWN

KSS

M

ROST

Retail and apparel stocks are experiencing an uptick after Gap and Ross Stores reported robust earnings. This positive sentiment may extend to other companies in the sector, reflecting investor optimism about the retail industry's performance.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 4:45 pm

RR

Shares of Richtech Robotics were halted due to a circuit breaker triggered by a rapid increase in the stock price. The halt is a temporary measure to prevent excessive volatility and allow the market to process the information that led to the sharp price movement.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 4:44 pm

RR

Richtech Robotics shares have resumed trading. There is no additional context provided in the article regarding the reason for the halt or the implications of the resumption.

Portfolio Pulse from Benzinga Newsdesk

November 17, 2023 | 4:43 pm